Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOX vs XELOX in Recurrent or Metastatic Gastric Cancer
NCT00985556Phase 2Unknown
- Sponsor
- Yonsei University
- Start
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tegafur in gastric cancer (GC), sponsored by Yonsei University. Status: unknown.
02
Drugs
tegafur
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00985556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00985556.